Poolbeg Pharma identifies new RSV drug candidates

News Direct

Dec 22, 2022

–News Direct–

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View original content to download multimedia: https://newsdirect.com/news/poolbeg-pharma-identifies-new-rsv-drug-candidates-240574752

YOU MAY ALSO LIKE

Market Alert: Silexion Therapeutics (NASDAQ: SLXN) Sees…

--News Direct--Contact DetailsProactive UK Ltd+44 20 7989 0813uk@proactiveinvestors.comView original content to download multimedia: https://newsdirect.com/news/poolbeg-pharma-identifies-new-rsv-drug-candidates-240574752

read more

Benchmark International Reveals Key Questions Sellers Should…

--News Direct--Contact DetailsProactive UK Ltd+44 20 7989 0813uk@proactiveinvestors.comView original content to download multimedia: https://newsdirect.com/news/poolbeg-pharma-identifies-new-rsv-drug-candidates-240574752

read more

NAFA Opens Registration for Annual 2025 Institute…

--News Direct--Contact DetailsProactive UK Ltd+44 20 7989 0813uk@proactiveinvestors.comView original content to download multimedia: https://newsdirect.com/news/poolbeg-pharma-identifies-new-rsv-drug-candidates-240574752

read more